{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:12:12Z","timestamp":1761621132242},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/lgt.0b013e318281f182","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T16:01:29Z","timestamp":1366214489000},"page":"430-439","source":"Crossref","is-referenced-by-count":5,"title":["Yield and Mode of Diagnosis of Cervical Intraepithelial Neoplasia 3 or Cancer Among Women With Negative Cervical Cytology and Positive High-Risk Human Papillomavirus Test Results"],"prefix":"10.1097","volume":"17","author":[{"given":"Robert G.","family":"Pretorius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome L.","family":"Belinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Famaraz","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210126","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomized controlled trial.","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"R2-11-20210126","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final result of the POBASCM randomized controlled trial.","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol"},{"key":"R3-11-20210126","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1470-2045(09)70246-3","article-title":"Further analysis of the ARTISTIC trial.","volume":"10","author":"Sasieni","year":"2009","journal-title":"Lancet Oncol"},{"key":"R4-11-20210126","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/ijgc-00009577-200311000-00013","article-title":"Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology.","volume":"13","author":"Belinson","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"R5-11-20210126","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1309\/AJCPKA6ATAPBZ6JQ","article-title":"A population-based clinical trial comparing endocervical high-risk HPV testing using Hybrid capture 2 and Cervista from the SHENCCAST II study.","volume":"135","author":"Belinson","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"R6-11-20210126","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/AOG.0b013e3181996ffa","article-title":"Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting.","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R7-11-20210126","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomized controlled implementation trial.","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"key":"R8-11-20210126","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.","volume":"377","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"R9-11-20210126","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jnci\/djj209","article-title":"Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.","volume":"98","author":"Ronco","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R10-11-20210126","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ajog.2007.07.050","article-title":"Solomon D, for the 2006 American Society for Colposcopy and Cervical Pathology-Sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical screening tests.","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R11-11-20210126","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.","volume":"100","author":"Rodriguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R12-11-20210126","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","article-title":"Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV cytology negative results.","volume":"136","author":"Wright","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"R13-11-20210126","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","article-title":"Human papillomavirus testing in the prevention of cervical cancer.","volume":"103","author":"Schiffman","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R14-11-20210126","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/jmv.22081","article-title":"Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.","volume":"83","author":"Coutlee","year":"2011","journal-title":"J Med Virol"},{"key":"R15-11-20210126","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/aje\/kwp188","article-title":"Human papillomavirus testing for cervical cancer screening: results from a 6-year prospective study in rural China.","volume":"170","author":"Shi","year":"2009","journal-title":"Am J Epidemiol"},{"key":"R16-11-20210126","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/gyno.2001.6370","article-title":"Shanxi Province cervical cancer screening study. A cross sectional comparative trial of multiple techniques to detect cervical intraepithelial neoplasia.","volume":"83","author":"Belinson","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R17-11-20210126","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.ajog.2006.07.036","article-title":"Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less.","volume":"195","author":"Pretorius","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R18-11-20210126","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/ijc.26202","article-title":"Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing.","volume":"130","author":"Belinson","year":"2012","journal-title":"Int J Cancer"},{"key":"R19-11-20210126","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2011.02.033","article-title":"Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16Ki-67 dual-stained cytology.","volume":"121","author":"Petry","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R20-11-20210126","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1128\/JCM.06587-11","article-title":"High-risk papillomavirus (hrHPV) E6E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology.","volume":"50","author":"Rijkaart","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R21-11-20210126","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/LGT.0b013e31824f48c8","article-title":"Secondary screening after primary self-sampling for human papillomavirus from SHENCCAST II.","volume":"16","author":"Wu","year":"2012","journal-title":"J Lower Gen Tract Dis"}],"container-title":["Journal of Lower Genital Tract Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/LGT.0b013e318281f182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:00:30Z","timestamp":1620957630000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00128360-201310000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/lgt.0b013e318281f182","relation":{},"ISSN":["1089-2591"],"issn-type":[{"value":"1089-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}